Archive for October, 2004

Beleaguered Merck looks to future

Beleaguered Merck looks to future “A week after saying it was withdrawing its $2.5 billion arthritis drug Vioxx from the market and losing a quarter of its stock market value as a result, Merck & Co. will try to dodge the storm clouds and turn its attention tomorrow to a brighter subject with the official […]



%d bloggers like this: